B
2.80
-2.60 (-48.15%)
| Previous Close | 5.40 |
| Volume | 13,524,071 |
| Price / Sales | 0.670 |
| Price / Book | 2.18 |
| 52 Weeks Range |
| Profit Margin | 4.28% |
| Operating Margin (TTM) | -11.31% |
| Diluted EPS (TTM) | 0.010 |
| Quarterly Revenue Growth (YOY) | -1.00% |
| Quarterly Earnings Growth (YOY) | -36.70% |
| Total Debt/Equity (MRQ) | 74.26% |
| Current Ratio (MRQ) | 1.88 |
| Operating Cash Flow (TTM) | -1.42 M |
| Levered Free Cash Flow (TTM) | 11.22 M |
| Return on Assets (TTM) | -1.21% |
| Return on Equity (TTM) | 6.10% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Mixed |
| Medical Care Facilities (Global) | Bullish | Mixed | |
| Stock | Basel Medical Group Ltd | - | - |
AIStockmoo Score
| Value 35% | -5.0 |
| AI Insight info | NA |
| Relative Valuation info | NA |
| Financial Health info | -5.0 |
| Timing 35% | 2.2 |
| AI Technical info | NA |
| Technical Oscillators info | 2.0 |
| Technical Moving Averages info | 2.5 |
| Smart Money 30% | 0.0 |
| Analyst Consensus info | 0.0 |
| Insider Activity info | NA |
| Environment | ×1.08 |
| Macro Environment info | -3.3 |
| Sector vs Market (6M) | +8.8% |
| Pillar Agreement | ×0.94 |
| Not in score | |
| Price Volatility info | 2.2 |
| Final Score | -1.00 |
Select this tab to load the latest available analysis.
|
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Key revenue is generated from Singapore. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| % Held by Insiders | 67.81% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Polaris Financial Partners | 30 Sep 2026 | 1 |
| Coston, Mcisaac & Partners | 30 Sep 2026 | 0 |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |